Navigation Links
Kessler Foundation implements Ekso Bionics' first commercial robotic exoskeleton
Date:3/1/2012

WEST ORANGE, N.J. -- On Monday, Kessler Foundation became the second rehabilitation research center in the U.S. to implement Ekso, a wearable, robotic battery-powered exoskeleton that allows wheelchair users with lower-extremity weakness to stand and walk.

"Kessler Foundation makes strategic investments in innovative technology that have the potential to improve the quality of life of people with disabilities," said Rodger DeRose, president and chief executive officer of Kessler Foundation. "Our partnership with Ekso Bionics confirms our leadership in rehabilitation research."

Made by Ekso Bionics, the new commercial version of Ekso is being distributed to the company's ten charter partnersincluding Kessler Foundation, for further testing. In October 2011, Foundation researchers successfully tested a prototype of Ekso on six participants with spinal cord injuries; five had paraplegia and one had tetraplegia, a higher level of injury. Each took steps in Ekso that were documented on video.

Scientists at Kessler Foundation are looking beyond the gains in mobility to the potential impact of standing and walking on overall health and well being. According to lead investigator Gail Forrest, PhD, they will study the effects on circulation, bone density, muscle strength, cardiac and lung function, mood, and bowel and bladder function. The outlook is promising according to preliminary research data collected for two participants during the October testing week. Protocols will be developed for using the device and identifying who will benefit from its use. Establishing an evidence base for safety and efficacy may support Ekso's use as a therapeutic rehabilitation device for mobility impairments caused by spinal cord injury and other conditions.

Kessler Foundation will collaborate with Kessler Institute for Rehabilitation for the Ekso studies, which will enable researchers and physical therapists to work together to determine best practices. Ekso Bionics plans to market a unit for home use in latter 2013.


'/>"/>
Contact: Carolann Murphy
CMurphy@kesslerfoundation.org
973-324-8382
Kessler Foundation
Source:Eurekalert

Related biology news :

1. Kessler Foundation neuroscientist Jordan Grafman receives Humboldt Research Award
2. Kessler Foundation tests Ekso exoskeletal device in 6 patients with traumatic spinal cord injury
3. Celebrity Golf Classic raises $553,443 for Seena Magowitz Foundation
4. Wayne State-licensed technology receives grant from the Foundation Fighting Blindness
5. National Science Foundation supports research aimed at reducing the use of fertilizer
6. UofL researcher earns the Foundation for Polish Science Prize
7. Elsevier Foundation 2011 grants for women in science and libraries in developing countries
8. National Science Foundation awards major grant to Cary Institute
9. The Michael J. Fox Foundation awards nearly $200,000 to develop novel drugs for Parkinsons disease
10. National Science Foundation makes first awards in Sustainability Research Coordination Program
11. Peggy Lillis Foundation honors Dr. Sherwood Gorbach for career combating C. diff infection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2019)... ... June 24, 2019 , ... According to the ... of the four most common STDs: chlamydia, gonorrhea, trichomoniasis (or "trich") and syphilis. And ... gay and bisexual African American men accounted for the largest number of HIV diagnoses ...
(Date:6/16/2019)... ... June 14, 2019 , ... ... to lecture at the fifth annual Neodent World Congress. Attended by thousands of ... progress and latest advancements in the world of dentistry. The three-day event featured ...
(Date:6/13/2019)... ... 13, 2019 , ... Global Clinical and Ancillary Supply Chain ... and ancillary supply chain management needs of large- and middle-market pharmaceutical, biotechnology, and ... it will sponsor a summer education program offered by the Young Men and ...
Breaking Biology News(10 mins):
(Date:7/11/2019)... ... July 11, 2019 , ... At the most recent ... therapies to eight military Veterans under the R3 Heroes Program. The Veterans included individuals ... R3 Heroes Program allow anyone to nominate a military Veteran, teacher or first responder ...
(Date:6/18/2019)... ... June 17, 2019 , ... ... entered into an agreement for production and manufacturing of GMP-grade adeno-associated virus (AAV) ... rhodopsin-mediated autosomal dominant retinitis pigmentosa (RHO-adRP) and IC-200 for the treatment of BEST1 ...
(Date:6/11/2019)... CITY, Calif. (PRWEB) , ... June 10, 2019 ... ... (IOPP) today announced IOPP will add 80 of its scientific journals to DeepDyve’s ... of physics-related content to DeepDyve’s continually expanding library of more than 20 million ...
(Date:5/31/2019)... ... May 29, 2019 , ... For many years, the primary forms ... cancer demand breakthrough therapies. Advances in immuno-oncology have led to the advent of Chimeric ... with engineered T cell receptors known as “CARs”. The CAR enables the final product ...
Breaking Biology Technology: